Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$49.38 - $63.75 $2.71 Million - $3.49 Million
-54,815 Reduced 4.05%
1,298,285 $80.8 Million
Q3 2023

Nov 14, 2023

BUY
$48.64 - $62.51 $1.14 Million - $1.46 Million
23,393 Added 1.76%
1,353,100 $75.9 Million
Q2 2023

Aug 14, 2023

BUY
$47.99 - $60.21 $966,182 - $1.21 Million
20,133 Added 1.54%
1,329,707 $67.1 Million
Q1 2023

May 15, 2023

BUY
$52.6 - $67.34 $2.4 Million - $3.07 Million
45,604 Added 3.61%
1,309,574 $71.5 Million
Q4 2022

Feb 14, 2023

BUY
$59.56 - $76.6 $2 Million - $2.57 Million
33,529 Added 2.72%
1,263,970 $79 Million
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $1.47 Million - $1.98 Million
25,358 Added 2.1%
1,230,441 $86.7 Million
Q2 2022

Aug 15, 2022

BUY
$39.5 - $64.42 $5.82 Million - $9.49 Million
147,246 Added 13.92%
1,205,083 $68.3 Million
Q1 2022

May 16, 2022

BUY
$43.74 - $62.76 $1.44 Million - $2.06 Million
32,826 Added 3.2%
1,057,837 $66.2 Million
Q4 2021

Feb 14, 2022

BUY
$50.01 - $73.35 $7.3 Million - $10.7 Million
146,008 Added 16.61%
1,025,011 $57.4 Million
Q3 2021

Nov 15, 2021

SELL
$59.21 - $78.66 $1.7 Million - $2.26 Million
-28,737 Reduced 3.17%
879,003 $57.2 Million
Q2 2021

Aug 13, 2021

BUY
$51.39 - $66.9 $12.4 Million - $16.1 Million
240,907 Added 36.13%
907,740 $57.6 Million
Q1 2021

May 17, 2021

BUY
$49.14 - $59.89 $7.01 Million - $8.54 Million
142,642 Added 27.21%
666,833 $39.9 Million
Q4 2020

Feb 16, 2021

BUY
$42.19 - $51.5 $11.2 Million - $13.7 Million
265,766 Added 102.84%
524,191 $26.2 Million
Q3 2020

Nov 16, 2020

BUY
$35.33 - $51.04 $9.13 Million - $13.2 Million
258,425 New
258,425 $13.2 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.45B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Hood River Capital Management LLC Portfolio

Follow Hood River Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hood River Capital Management LLC with notifications on news.